Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 26, 2021

SELL
$150.19 - $173.5 $240,304 - $277,600
-1,600 Closed
0 $0
Q3 2020

Oct 19, 2020

BUY
$105.46 - $144.13 $168,736 - $230,608
1,600 New
1,600 $228,000
Q1 2020

Apr 16, 2020

SELL
$87.74 - $152.74 $145,648 - $253,548
-1,660 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$142.62 - $155.6 $236,749 - $258,296
1,660
1,660 $243,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.6B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Brave Asset Management Inc Portfolio

Follow Brave Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brave Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brave Asset Management Inc with notifications on news.